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Type I interferon (IFN) is a critical antiviral response of the host. We found that Interferon Regulatory
Factor 3 (IRF-3) was responsible for induction of type I IFN following mouse gammaherpesvirus-68
(MHV68) infection of primary macrophages. Intriguingly, type I IFN signaling was maintained throughout
the entire MHV68 replication cycle, in spite of several known viral IFN antagonists. However, MHV68-
infected primary macrophages displayed attenuated responses to exogenous type I IFN, suggesting that
MHV68 controls the level of type I IFN signaling that is allowed to occur during replication. Type I IFN
receptor and IRF-3 were necessary to attenuate transcription of MHV68 RTA, an immediate early gene
critical for replication. Furthermore, higher constitutive activity of RTA promoters was observed in the
absence of type I IFN signaling. Our study suggests that MHV68 has preserved the ability to sense type I
IFN status of the host in order to limit lytic replication.
& 2013 Elsevier Inc. All rights reserved.Introduction
Type I interferon (IFN) signaling network is an innate defense
system of the host with potent antiviral activity. In a canonical
signaling pathway, virus products, such as double stranded RNA,
are recognized by a combination of cytoplasmic and membrane-
associated pattern recognition receptors. These pattern recogni-
tion receptors initiate signaling that activates interferon regulatory
factors (IRF) 3 and 7. Upon activation, IRF-3 and IRF-7 stimulate
transcription of several type I IFN genes, including IFNβ and IFNα.
All members of type I IFN family interact with a single receptor
(IFNAR) that is critical for signal propagation [reviewed in
Platanias (2005)]. Engagement of the type I IFN receptor leads to
activation of receptor-associated kinases Jak1 and Tyk2 that
phosphorylate speciﬁc residues of Stat1 and Stat2. A complex of
phosphorylated Stat1, Stat2, and IRF9 (ISGF3) subsequently med-
iates transcription of hundreds of cellular genes that collectively
create an antiviral state. Importantly, only a handful of IFN-
stimulated genes (ISG) have proven antiviral functions in the
context of a particular virus infection; furthermore, the mechan-
ism by which these antiviral functions are conferred is generally
poorly understood.
Gammaherpesviruses, such as Epstein-Barr virus (EBV) and
Kaposi's sarcoma associated herpesvirus (KSHV), establish a life-long
infection in a majority of human population and are associated with
several malignancies. Similar to a plethora of other viruses,ll rights reserved.
8701 Watertown Plank Road,
6535.
edu (V.L. Tarakanova).gammaherpesviruses encode a number of proteins that interfere with
type I IFN induction and signaling [reviewed in Versteeg and Garcia-
Sastre (2010); Sathish and Yuan (2011)]. Induction of type I IFN in
gammaherpesvirus-infected cells is in part controlled by KSHV tegu-
ment protein orf45 that interacts with and inhibits phosphorylation of
IRF-7 (Zhu et al., 2002). Virion-associated KHSV orf64 reduces activa-
tion of RIG-I, a cytosolic sensor that initiates type I IFN cascade (Inn
et al., 2011). Another tegument protein, a conserved protein kinase
encoded by EBV (BGLF4) and mouse gammaherpesvirus-68 (MHV68,
orf36), attenuates type I IFN induction by binding to IRF-3 and
inhibiting activity of IRF-3-driven promoters, including IFNβ
(Hwang et al., 2009;Wang et al., 2009). RTA is an immediate early
gammaherpesvirus transactivator that is essential for MHV68 and
KSHV replication and reactivation from latency (Liu et al., 2000;Lukac
et al., 1998;Sun et al., 1998;Wu et al., 2000, 2001). KSHV RTA targets
both IRF-3 and IRF-7 for degradation (Yu et al., 2005;Yu and Hayward,
2010). Importantly, the relative contributions of IRF-3 and IRF-7 to the
induction of type I IFN response in gammaherpesvirus-infected cells
have not been deﬁned.
Type I IFN signaling is further inhibited by another cohort of
gammaherpesvirus proteins. KSHV RIF (encoded by orf10) forms
complexes with type I IFN receptor and receptor-associated
kinases Jak1 and Tyk2 to attenuate type I IFN signaling (Bisson
et al., 2009). MHV68-encoded M2 protein interferes with type I
IFN signaling concurrent with downregulation of STAT2 expression
(Liang et al., 2004). Another MHV68 protein encoded by orf54
targets type I IFN receptor for degradation (Leang et al., 2011).
Paradoxically, some of gammaherpesvirus proteins appear
to have a positive effect on type I IFN signaling. Speciﬁcally,
EBV-encoded lytic Sm protein induces Stat1 phosphorylation
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B.M. Wood et al. / Virology 443 (2013) 123–133124(Ruvolo et al., 2003). Intriguingly, LMP1, a latent EBV protein, has
been shown to both activate and suppress type I IFN signaling
(Zhang et al., 2004; Xu et al., 2006; Geiger and Martin, 2006).
A majority of studies examining the regulation of type I IFN
signaling by EBV- or KSHV-encoded proteins have been done in
the context of protein overexpression and/or using transformed cell
lines. Because type I IFN responses are altered upon transformation
(Tomic et al., 2011; Clifford et al., 2002; Klampfer et al., 2003), it is
not clear whether the same regulation of type I IFN signaling is
preserved during infection of primary, physiologically relevant cell
types. Signiﬁcantly, infection of primary human foreskin ﬁbroblasts
and endothelial cells with KSHV leads to a signiﬁcant induction of
ISG at 2 and 4 h post infection (Naranatt et al., 2004). Furthermore,
live, but not UV-inactivated KSHV infection increased activation and
type I IFN production in plasmacytoid dendritic cells (West et al.,
2011); however, it is not clear whether KSHV can adequately
express all of its lytic genes to undergo productive replication in
this cell type. Thus, gammaherpesvirus infection of primary cells is
likely to induce type I IFN signaling, in spite of several type I IFN
inhibitors (including tegument proteins) encoded by the virus.
MHV68 is genetically and biologically related to EBV and KSHV
(Efstathiou et al., 1990; Virgin et al., 1997) and offers a powerful
experimental system to dissect virus–host interactions in the context
of primary cell types and in vivo. Similar to that observed for human
gammaherpesviruses in vitro (Chang et al., 2000; Krug et al., 2004;
Monini et al., 1999; Perry and Compton, 2006), type I IFN plays an
important role in controlling MHV68 replication in vitro and chronic
infection in vivo (Barton et al., 2005; Dutia et al., 1999; Hwang et al.,
2009; Mandal et al., 2011). Overexpression of several ISG prior to
MHV68 infection restricts MHV68 replication (Liu et al., 2012);
however, the mechanism by which type I IFN attenuates MHV68 lytic
infection is poorly understood. We have recently reported that
activation of the DNA damage response, a major tumor suppressor
system of the host, stimulates type I IFN and ISG expression in pri-
mary macrophages (Mboko et al., 2012). MHV68-infected primary
macrophages were resistant to further increase in ISG expression upon
irradiation, suggesting that the virus uncouples the connection
between the DNA damage response and type I IFN signaling. Intrigu-
ingly, we observed elevated baseline ISG expression in MHV68-
infected macrophages at an advanced stage of infection [36 h post
infection (Mboko et al., 2012)], suggesting that type I IFN signaling is
active in infected cells. In this study we show that, following de novo
infection of primary macrophages, type I IFN signaling was induced as
early as 4 h post infection and was maintained throughout the entire
viral replication cycle. IRF-3 was critical for type I IFN induction during
the early stage of lytic MHV68 infection. In spite of active IFN signaling
during infection, response to increased levels of exogenous type I IFN
was attenuated in infected macrophages, suggesting that the MHV68
infection functions as a rheostat that sets a deﬁned level of type I IFN
signaling in infected cells. Finally, expression of RTA, an immediate
early viral transactivator, and activity of RTA promoters were elevated
in macrophages lacking type I IFN receptor, suggesting that MHV68
has evolved to sense the innate immune status of the host in order to
control its lytic replication. STAT1
β -actin
Fig. 1. MHV68 infection of primary macrophages is associated with increased
phospho- and total Stat1 levels. Primary macrophages were derived from bone
marrow isolated from BL6 (wt) (A) or IFNAR1-/- (B) mice. Macrophages were mock-
treated or infected with live wt MHV68, N36S mutant, or UV-inactivated wt
MHV68 at an MOI of 10. Cell lysates were collected at indicated times post infection
and levels of total Stat1, tyrosine 701-phosphorylated Stat1, and β-actin measured
by western analysis. Images representative of 3–5 independent experiments are
shown. Western blots measuring levels of tyrosine 701-phosphorylated Stat1 in A
and B were performed and developed concurrently and represent the same
exposure time.Results
MHV68 infection of primary macrophages is associated with
increased phospho- and total Stat1 levels
We have recently shown that activation of the DNA damage
response induces type I IFN signaling (Mboko et al., 2012).
Irradiation failed to further increase ISG expression in MHV68-
infected macrophages, suggesting that the virus blocked DNA
damage-induced transcription of ISG. Intriguingly, even in theabsence of irradiation, a signiﬁcant increase in transcription of two
antiviral ISG (viperin and Mx1) was observed in MHV68-infected
macrophages at an advanced stage in viral replication [36 h post
infection (Mboko et al., 2012)], suggesting that IFN signaling may
already be active in infected cells. To further dissect the status of
type I IFN signaling during infection, primary bone marrow
derived macrophages were mock-treated or infected with wt
MHV68, N36S viral mutant that lacks expression of orf36, a viral
kinase responsible for inhibition of IRF-3 in ﬁbroblasts (Hwang
et al., 2009), or UV-inactivated wt MHV68 to control for the effects
of the virus particle and tegument proteins.
Phosphorylation of Stat1 Y701 (α and β isoforms) was induced
as early as 4 h post infection with wt MHV68, N36S, or UV-
inactivated wt virus (Fig. 1A). Levels of phosphorylated Stat1
peaked at 4 h post infection and decreased thereafter. Importantly,
phosphorylated Stat1 levels remained above background in wt
MHV68- and N36S-infected macrophages for the duration of the
replication cycle (48 h, Fig. 1A), suggesting that some level of type I
IFN signaling was maintained throughout the infection. Mainte-
nance of phosphorylated Stat1 required viral gene expression
and/or replication, as phosphorylated Stat1 was no longer detected
in macrophages infected with UV-inactivated MHV68 by 24 h post
infection. Consistent with a positive feedback loop mediated by
Stat1 (Cheon and Stark, 2009), total Stat1 levels increased in
B.M. Wood et al. / Virology 443 (2013) 123–133 125infected macrophages by 8 h post infection and remain elevated
for the duration of the replication cycle (Fig. 1A). Importantly,
infection of IFNAR1-/- macrophages failed to upregulate either
total or phosphorylated Stat1 levels (Fig. 1B). Thus, MHV68
infection of primary macrophages induced an early Stat1 phos-
phorylation that was maintained for the duration of the replicative
cycle and required active viral replication and expression of type I
IFN receptor.Expression of type I IFN receptor is required for induction of interferon
stimulated genes (ISG) in MHV68-infected primary macrophages
In a canonical type I IFN signaling pathway, phosphorylation of
Stat1 triggers the assembly of the ISGF3 transcriptional complex that
culminates in increased transcription of a large number of ISG,
including those with known antiviral functions. Having observed
increased levels of total and phospho-Stat1 in infected macrophages,
we wanted to determine whether transcription of antiviral ISG wasMx1
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Fig. 2. Expression of type I IFN receptor is required for induction of interferon stimulate
derived macrophages were generated from BL6 or IFNAR1-/- mice. Macrophages were
infection. Mx1 and viperin mRNA levels were measured by qRT-PCR. Relative levels of
expressed as fold induction. Data were pooled from 3 to 5 independent experiments, with
data are shown as average with standard error of measurement. C. Primary BL6 derived m
measured at 24 and 48 h post infection. Data is representative of 3 independent experiincreased in MHV68-infected cells concurrent with increase in
phospho-Stat1.
Indeed, transcription of Mx1 and expression of viperin, ISGs
with known antiviral function (Pavlovic et al., 1992; Wang et al.,
2007), peaked at 8 h post infection and was sustained for the
duration of replicative cycle in wt MHV68- and N36S-infected
macrophages (Fig. 2A–C). Importantly, peak expression of Mx1 and
viperin was lower in macrophages infected with UV-inactivated
MHV68 (Fig. 2A and B). Mx1 and viperin mRNA levels further
declined to baseline by 24 h post infection with UV-inactivated
virus (Fig. 2A and B), suggesting that a UV-sensitive virion
component and active viral gene expression were necessary for
peak induction and sustained transcription of ISG in MHV68-
infected macrophages. Type I IFN signaling was required for ISG
transcription throughout the infection, as ISG mRNA levels
remained at baseline in IFNAR1-/- macrophages under all experi-
mental conditions (Fig. 2D and E, data not shown). Consistent
with the phenotype of the N36S virus mutant in ﬁbroblasts
(Hwang et al., 2009), increased Mx1 and viperin mRNA levelsViperin
8 hours post infection
Viperin
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mRNA present in BL6 mock-infected cells were set to 1 and the rest of the data
each experimental condition assessed in duplicate within each experiment. Pooled
acrophages were infected as described above and viperin and β-actin protein levels
ments.
B.M. Wood et al. / Virology 443 (2013) 123–133126were observed in N36S-infected cells as compared to wt MHV68-
infected cells at 48 h post infection (Fig. 2A, 2.1-fold difference;
Fig. 2B, 3.3-fold difference). In summary, transcription of ISG was
induced early in MHV68 infection and was sustained for the
duration of the replication cycle. Both peak and sustained ISG
expression required live virus and expression of host IFNAR1.
IRF-3 plays a critical role in the induction of type I IFN responses
during early MHV68 infection
IRF-3 was initially shown to play an important role in the
induction of type I IFN expression following Newcastle Disease
virus infection (Yoneyama et al., 1998) and was later found to have
a more global role in type I IFN induction by several viruses.
Importantly, IRF-3 is dispensable for induction of type I IFN in
response to myxoma virus infection of dendritic cells in vitro and
infection with West Nile virus virus-like particles in vivo (Bourne
et al., 2007; Dai et al., 2011). Because IRF-3 is targeted by KSHV
RTA and by orf36 in MHV68-infected ﬁbroblasts (Hwang et al.,
2009; Yu and Hayward, 2010), we expected that IRF-3 would only
partially contribute to the robust induction of type I IFN responses
in MHV68-infected macrophages during early infection. Surpris-
ingly, at 8 h post infection, when peak levels of Mx1 and viperin
mRNA are observed in MHV68-infected macrophages, transcrip-
tion of Mx1 and viperin was abolished in IRF-3 deﬁcient macro-
phages under all experimental conditions (Fig. 3A, data not
shown), suggesting that IRF-3 plays a critical and unique role in
increased ISG transcription during early MHV68 infection.
Because IFNAR1 and IRF-3 expression were required for
increased transcription of Mx1 and viperin at 8 h post infection
(Figs. 2D, E and 3A), it was likely that IRF-3 was driving type I IFN
induction shortly following virus entry. Over a dozen of type I IFN
family members interact with type I IFN receptor to induce
signaling [reviewed in (Platanias, 2005)]. Therefore, we employed
EMCV bioassay to capture production of any type I IFN by infected
macrophages. Primary macrophages isolated from control (BL6),
IFNAR1-/-, or IRF-3-/- mice were mock-treated, infected with live
MHV68 or UV-inactivated virus, and antiviral activity of culture
supernatants measured during the ﬁrst four hours of infection.
Very little antiviral activity was observed under all experimental
conditions during the ﬁrst two hours of infection (Fig. 3B).
However, increased antiviral activity was seen in supernatants
collected at 3 and 4 h post infection from BL6 and IFNAR1-/-
macrophages infected with live MHV68 (Fig. 3B and C). EMCV
antiviral activity was also present in the supernatants collected
at 4 h post infection from UV virus-infected BL6 and IFNAR1
-/- macrophages, although this antiviral activity remained signiﬁ-
cantly lower than that induced by live MHV68 (Fig. 3B and C). In
contrast, antiviral activity was not detected in any of the super-
natants collected from IRF-3-/- cultures (Fig. 3D). Consistent with
the bioassay results, mRNA levels of IFNα and IFNβ increased in
virus-infected BL6 macrophages, but not in IRF-3 deﬁcient cultures
at 4 h post infection (Fig. 3E). Thus, IRF-3 functioned upstream of
IFNAR1 to induce secreted antiviral activity and type I IFN
transcription in infected macrophages.
To determine the relative importance of IRF-3 in type I IFN
responses later in MHV68 infection, levels of Stat1 and ISG15 were
measured in wild type (BL6) and IRF-3-/- macrophages infected
with either wt MHV68 or the N36S mutant. Both free and
conjugated forms of ISG15 were increased in infected BL6 macro-
phages at 24 and 48 h post infection (Fig. 3F); this increase was
similar in wt- and N36S-infected cultures. In contrast, minimal
ISG15 induction was seen in IRF3-/- macrophages infected with wt
MHV68 at both 24 and 48 h post infection. Surprisingly, some
induction of ISG15 was observed in IRF-3-/- macrophages infected
with the N36S mutant at 24 and 48 h post infection (Fig. 3F). TotalStat1 levels were minimally induced in IRF3-/- macrophages at
24 h post infection. However, appreciable induction of total Stat1
was observed at 48 h post infection in the absence of IRF-3.
Because increased expression of total Stat1 is dependent on type
I IFN signaling (Fig. 1B), these results suggest that another
mechanism of type I IFN induction compensated for IRF-3 deﬁ-
ciency at a late stage of MHV68 infection. While total Stat1 levels
were similarly induced in wt MHV68- and N36S-infected BL6
macrophages (Fig. 1A), Stat1 levels were higher in N36S-infected
IRF-3-/- macrophages at 48 h post infection (Fig. 3F), suggesting
that, in addition to IRF-3 (Hwang et al., 2009), orf36 is likely to
inhibit another component of type I IFN induction/signaling net-
work. Consistent with the proposed role of orf36 in counteracting
IRF-3-independent IFN induction in infected macrophages,
phospho-Stat1 levels were increased in N36S-infected, but not
wt MHV68-infected IRF-3 deﬁcient macrophages at 24 h post
infection (Fig. 3G).
MHV68 infection attenuates further Stat1 phosphorylation upon
exogenous IFNβ treatment
Although phospho-Stat1 and ISG transcription were detected in
MHV68-infected macrophages, the extent to which MHV68 con-
trolled type I IFN signaling was not clear. Thus, exogenous IFNβ
treatment was used to test the ability of infected cells to respond
to further stimulation of type I IFN signaling. At 24 h post
infection, mock, wt-, and N36S-infected macrophages were trea-
ted with recombinant mouse IFNβ and total and phospho-Stat1
levels measured at the end of cytokine or mock treatment. Low
concentration of IFNβ (10 U/ml) increased phospho-Stat1 levels in
mock-infected cells between 15 and 60 min of treatment (Fig. 4).
Similar IFNβ treatment did not induce the same increase in Stat1
phosphorylation in wt MHV68- or N36S-infected macrophages. As
expected, high levels of phospho-Stat1 were induced in mock-
infected cells treated with 100 U/ml of IFNβ. Importantly, wt
MHV68- and N36S-infected macrophages showed attenuated
phospho-Stat1 levels even following treatment with high dose of
exogenous IFNβ (Fig. 4, 100 U/ml). This attenuated Stat1 phosphor-
ylation in response to exogenous cytokine occurred in spite of an
increase in total Stat1 levels observed in infected cells at 24 h post
infection (Figs. 4 and 1A). Thus, MHV68 infection controlled the
extent of Stat1 phosphorylation within infected macrophages.
Type I IFN signaling represses RTA expression
Live MHV68 triggered type I IFN signaling within the ﬁrst 4 h of
infection, and this signaling persisted throughout the entire
MHV68 replication cycle (Figs. 1–3). Virus-induced type I IFN
signaling was inhibitory, as MHV68 replication was enhanced in
macrophages derived from IFNAR1-/- mice (Fig. 5A). As expected,
attenuated replication of the N36S viral mutant was partially
rescued in IFNAR1-/- macrophages (Fig. 5A). Consistent with the
role of IRF-3 in the induction of type I IFN, replication of wt
MHV68 was also increased in IRF-3 deﬁcient macrophages
(Fig. 5B). Enhanced viral replication in IRF-3-/- macrophages was
most obvious at 24 h post infection and never reached the same
magnitude as compared to wt MHV68 replication in IFNAR1-/-
macrophages, consistent with induction of type I IFN responses at
a later stage of MHV68 infection in IRF-3-/- macrophages (Fig. 3F).
As expected (Hwang et al., 2009), replication of the orf36 null
N36S virus mutant was partially rescued in IRF-3-/- macrophages
(Fig. 5B).
To further deﬁne the step of MHV68 replication attenuated by
type I IFN, immediate early viral gene transcription was measured
in BL6 and IFNAR1-/- macrophages. RTA is an immediate early
gammaherpesvirus gene that is critical for viral replication and
Fig. 3. IRF-3 is required for induction of type I IFN responses during early MHV68 infection. Primary bone marrow derived macrophages were generated from BL6 (Wt),
IFNAR1-/-, or IRF-3-/- mice. Macrophages were infected as described in Fig. 1. A. Total RNA was harvested at 8 h post infection and subjected to qRT-PCR to measure viperin
mRNA levels. B–D. EMCV bioassay was used to measure antiviral activity of conditioned tissue culture medium collected at indicated times post infection. Conditioned tissue
culture medium was UV-irradiated prior to the bioassay. E. mRNA levels were measured at 4 h post infection using universal primers against IFNα or IFNβ sequences,
respectively. F, E. Protein levels of β-actin, ISG15, total STAT1, and phospho-Stat1 were measured by western analysis at 4, 24 and 48 h post infection as indicated. Both free
and conjugated forms of ISG15 are indicated. Data are representative of 2–3 independent experiments. Within an experiment, each experimental condition was done in
duplicate, with average and standard error shown.
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Fig. 4. MHV68 infection prevents further Stat1 phosphorylation upon exogenous
IFNβ treatment. Primary bone marrow derived macrophages (BL6) were mock-
infected or infected with live MHV68 or N36S virus mutant at an MOI of 10. At 23 h
post infection, cultures were mock-treated or treated with indicated amounts of
exogenous IFNβ, and cell lysates collected at indicated times post treatment or at
24 h post infection. Levels of Y701-phosphorylated Stat1, total Stat1, and β-actin
were measured by western analysis. Presented data is representative of two
independent experiments.
B.M. Wood et al. / Virology 443 (2013) 123–133128reactivation from latency (Liu et al., 2000; Lukac et al., 1998; Sun
et al., 1998; Wu et al., 2000, 2001). RTA mRNA levels were
signiﬁcantly increased in IFNAR1-/- macrophages at 8 h post
infection (Fig. 5C). The difference in RTA mRNA levels observed
at 8 h post infection in BL6 and IFNAR1-/- macrophages was no
longer seen at 24 h post infection (Fig. 5C), suggesting that type I
IFN-mediated attenuation of RTA transcription was counteracted
later in infection by an unknown viral mechanism. A similar
increase in RTA transcription was seen at 8 h post infection in
the absence of IRF-3 (Fig. 5D), consistent with the critical role of
IRF-3 in the induction of type I IFN response during early stages of
MHV68 infection (Fig. 3).
Increased expression of RTA in the absence of IFNAR1 or IRF-3
led to increased expression of MHV68 early genes. Speciﬁcally,
protein levels of MHV68 single stranded DNA binding protein
(ssDBP), a critical component of viral DNA replication machinery,
were increased in IFNAR1-/- and IRF-3-/- macrophages at 24 h
post infection (Fig. 5E). Later in infection (48 h) ssDBP levels
remained elevated in the absence of IRF-3 or IFNAR1 (Fig. 5F, data
not shown).
Consistent with an elevated expression of MHV68 ssDBP,
MHV68 DNA accumulation was increased in IRF-3-/- and
IFNAR1-/- macrophages (Fig. 5G and H). Furthermore, attenuated
viral DNA synthesis in the absence of orf36, was partially rescued
in the absence of IRF-3 or IFNAR1. Thus, type I IFN signaling
attenuated early stages of MHV68 replication and restricted
progression through the rest of the replication cycle.
MHV68 RTA transcription is inhibited by type II IFN in a Stat1-
dependent manner (Goodwin et al., 2010). Because RTA mRNA levels
were signiﬁcantly increased in IFNAR1-/- and IRF-3-/- macrophages at
8 h post infection, we wanted to further explore the effects of type I
IFN signaling on RTA expression. RTA transcription is driven by two
promoters, termed core and distal (Gray et al., 2008;Liu et al., 2000),
and is further ampliﬁed by RTA. Type II IFN represses both RTA
promoters (Goodwin et al., 2010); however, the effect of type I IFN on
the activity of RTA promoters has not been deﬁned. To determine the
extent to which type I IFN signaling affects the baseline activity of RTA
promoters, reporter plasmids containing either RTA promoter or a
control promoter-less vector (pGL4.10) were nucleofected into primary
macrophages and promoter activity assessed at 16 h post nucleofec-
tion. Both core and distal RTA promoters displayed low activity in
nucleofected primary macrophages derived from wt mice (Fig. 6A).
Interestingly, a signiﬁcantly higher activity of core and distal RTA
promoters, but not control vector, was observed in IFNAR1-/- macro-
phages as compared to wild type cells (3.5-fold increase for the core
promoter, 1.8-fold increase for the distal promoter, Fig. 6A).Pretreatment of macrophages with type II IFN suppresses RTA
transcription (Goodwin et al., 2010). To directly compare the
effects of type I and type II IFN, primary macrophages were
mock-treated or pretreated with 10U/ml of recombinant IFNβ or
IFNγ for 16 h, infected with wt MHV68, treated with the same
amount of IFNβ or IFNγ following virus absorption, and RTA mRNA
levels measured at 8 or 24 h post infection. Consistent with the
published study (Goodwin et al., 2010), IFNγ signiﬁcantly decreased
RTA transcription at 8 and 24 h post infection (Fig. 6B). A similar
magnitude of decrease was seen in infected macrophages that were
treated with IFNβ. Thus, type I IFN signaling suppressed the con-
stitutive activity of both RTA promoters independent of virus infec-
tion, and inhibited RTA transcription in MHV68-infected primary
macrophages.Discussion
In this manuscript we show that MHV68 infection of primary
macrophages induces type I IFN response that proceeds through
the entire signaling pathway culminating in increased transcrip-
tion of antiviral ISG. In spite of many type I IFN inhibitors encoded
by herpesviruses, activation of type I IFN signaling by individual
herpesvirus proteins or in the context of herpesvirus entry is not
without a precedent. Entry of human cytomegalovirus (HCMV)
initiates type I IFN signaling, including increased expression of
viperin, an ISG also examined in the present study (Juckem et al.,
2008; Chin and Cresswell, 2001). ISG induction is observed as
early as 2 h following KSHV infection of primary cells (Naranatt
et al., 2004) and both type I and type II IFN are constitutively
secreted into the supernatants of cultured lymphoblastoid cell
lines latently infected with EBV (Xu et al., 2006; Zhang et al.,
2004). Intriguingly, activation of type I IFN signaling was not
limited to early stages of MHV68 infection, but was, instead,
maintained throughout the entire replication cycle, in spite of
expression of viral type I IFN antagonists.
Triggering of pattern recognition receptors by viral constituents
is a classical mechanism that would be expected to induce type I
IFN signaling in infected cells. Consistent with this mechanism,
infection of primary macrophages with UV-inactivated MHV68
induced type I IFN signaling and both IRF-3 and IFNAR1 were
required for this induction (Figs. 1–3). Surprisingly, induction of
type I IFN signaling was stronger and persisted throughout the
entire replication cycle in macrophages infected with live MHV68,
as compared to UV-inactivated virus. This suggests that UV-
sensitive virion components contribute to induction of type I IFN
signaling in infected primary macrophages. It was previously
shown that repeat regions of MHV68 and KSHV DNA are sufﬁcient
to induce type I IFN (Sanchez et al., 2008); however, it is not clear
whether UV treatment alters the ability of repeat regions to
engage pattern recognition receptors. Furthermore, all virus stocks
used for this study were treated with DNase to eliminate stimula-
tion of pattern recognition receptors by unpackaged MHV68 DNA.
Induction of Mx1 and viperin transcription occurred as early as 4 h
post infection in macrophages infected with live MHV68, but not
UV-inactivated virus (Fig. 2A and B). Expression of RTA, an
immediate early gene, remains below the detection level for the
ﬁrst 5 h of infection under high MOI conditions (Mounce et al.,
2011b), suggesting that de novo viral gene expression is unlikely to
contribute to induction of ISG expression seen at 4 h post infection
in live MHV68-infected macrophages. EBV and MHV68 encode a
number of small viral RNAs that are packaged into the virion and
have recently been shown to regulate several cellular processes,
including cytokine expression, immediately following EBV infec-
tion of primary B cells (Jochum et al., 2012). It is intriguing to
speculate that virion-associated RNA also contributes to early
Fig. 5. Type I IFN signaling attenuates MHV68 replication in primary macrophages. Bone marrow derived macrophages were isolated from BL6 (Wt), IFNAR1-/-, or IRF-3-/-
mice. Macrophages were infected with wt MHV68 or the N36S mutant at an MOI of 10. A, B. Virus yield was measured at indicated times post infection. Data are
representative of three independent experiments. C, D. Total RNA was collected at indicated time post infection and RTA mRNA levels measured using qRT-PCR. Relative
levels of RTA mRNA in BL6 cells at 8 h post infection were set to 1, with the rest of the conditions normalized to BL6 8 h levels within each experiment. Data were pooled
from 2 to 3 independent experiments, with each experimental condition performed in duplicate within each experiment. E, F. Primary macrophages of indicated genotypes
were mock-infected or infected with wt MHV68 or the N36S mutant at an MOI of 10. MHV68 ssDBP and β-actin protein levels were measured by western analysis in cell
lysates collected at 24 and 48 h post infection. Data are representative of two independent experiments. G, H. Total DNA was isolated from BL6, IFNAR1-/-, or IRF-3-/-
macrophages infected with wt MHV68 or the N36S viral mutant. The relative amount of viral DNA was measured by real time PCR with subsequent normalization to cellular
DNA levels. Data are representative of 2–3 independent experiments, each data point derived from a biological triplicate with mean and standard error of
measurement shown.
B.M. Wood et al. / Virology 443 (2013) 123–133 129induction of type I IFN in MHV68-infected macrophages. Alter-
natively, a UV-sensitive virion protein may also function to induce
ISG transcription at 4 h post infection.
Once viral gene expression ensues, type I IFN signaling may
also be directly driven by viral proteins expressed in infected
macrophages. Consistent with this hypothesis, expression of
EBV-encoded lytic Sm protein is sufﬁcient to induce Stat1 phos-
phorylation (Ruvolo et al., 2003). Furthermore, expression of
HCMV immediate early IE1 induces ISG transcription that is
dependent on Stat1 expression and phosphorylation (Knoblach
et al., 2011). Alternatively, ongoing viral gene expression and
replication may create nucleic acid products that engage pattern
recognition receptors, contributing to sustained type I IFN signal-
ing in MHV68-infected macrophages.We have observed increasing levels of unphosphorylated Stat1
(uStat1) that accumulated in infected macrophages by 24 h post
infection (Fig. 1A). uStat1 is an active transcription factor with an
altered DNA binding preference (as compared to phosphorylated
Stat1) that mediates expression of immune and non-immune
genes in a cell type-speciﬁc manner (Cheon and Stark, 2009;
Yang and Stark, 2008). In the future it will be important to deﬁne
whether the accumulation of uStat1 in MHV68-infected macro-
phages has the capacity to regulate gammaherpesvirus infection.
While several gammaherpesvirus proteins are known to coun-
teract IRF-3, the role of IRF-3 in generating antiviral response in
EBV- or KSHV-infected cells has not been deﬁned. Here we show
that IRF-3 expression was critical for induction of type I IFN
signaling at 8 h post MHV68 infection, including in macrophages
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Fig. 6. Type I IFN signaling represses MHV68 RTA expression. A. Primary bone
B.M. Wood et al. / Virology 443 (2013) 123–133130infected with the orf36 null MHV68 mutant (N36S, Fig. 3A).
The fact that MHV68-mediated type I IFN induction was brought
to baseline in the absence of IRF-3 (Fig. 3D) was particularly
surprising in light of the well-established roles of MHV68 orf36
and its closely related EBV protein kinase in antagonizing IRF-3
(Hwang et al., 2009; Wang et al., 2009) and targeting of both IRF-3
and IRF-7 by KSHV RTA (Yu et al., 2005; Yu and Hayward, 2010).
The viral kinase-IRF-3 interaction was demonstrated exclusively in
ﬁbroblasts or epithelial cells. Because stromal cell types and
professional immune cells differ in their capacity to induce and
respond to type I IFN (Fang et al., 2012), it is possible that the
function of viral type I IFN antagonists may be modiﬁed in a cell
type-speciﬁc fashion. Gammaherpesvirus infection of other rele-
vant cell types, such as dendritic cells and B cells, may activate
additional IRF family members to trigger type I IFN expression.
Identifying cell type-speciﬁc signaling pathways that induce type I
IFN in response to gammaherpesvirus infection is an important
future endeavor. Intriguingly, our ﬁndings also suggest that, in
addition to IRF-3, orf36 regulates another aspect of type I IFN
induction and/or signaling, as expression of type I IFN-dependent
ISG15 and Stat1 and Stat1 phosphorylation was increased in IRF-
3-/- macrophages infected with the N36S mutant as compared to
wt virus, especially at later time points of replication (Fig. 3F, G).
This ﬁnding suggests that gammaherpesvirus infection of macro-
phages is likely to trigger multiple, IRF-3 dependent and indepen-
dent mechanisms of type I IFN induction that operate at different
times of the replication cycle.
Consistent with multiple type I IFN antagonists encoded by
gammaherpesviruses, we also show that MHV68 attenuates type I
IFN signaling induced by exogenous type I IFN (Fig. 4). It is intriguing
that MHV68 allows some degree of type I IFN signaling to be
maintained throughout the entire replication cycle, in spite of a
signiﬁcant detriment to viral replication (Fig. 5). Because gammaher-
pesviruses have evolved to maintain a lifelong infection, it is possible
that these viruses have developed mechanisms to limit viral replica-
tion and pathogenesis in an immunocompetent individual. In support
of this idea, our study shows that constitutive type I IFN signaling in
primary macrophages limits the activity of the RTA promoters
(Fig. 6A). The mechanism by which type I IFN suppresses RTA
transcription remains unclear. Several putative interferon gamma
activated sequences were identiﬁed in both core and distal RTA
promoters, however, these sequences are dispensable for Stat1-
mediated repression of RTA promoter activity in response to IFNγ
(Goodwin et al., 2010). MHV68 has evolved an interferon stimulated
response element in its M2 promoter that acts to repress M2
expression and, thus, limit viral lytic replication and reactivation
in vivo (Mandal et al., 2011). It is also possible that MHV68 may usurp
certain ISGs to facilitate its lytic or latent life cycle, similar to the
HCMV-driven induction of viperin that this virus coopts to enhance its
replication (Seo et al., 2011). Thus, it is prudent to explore virus-type I
IFN interactions not only from the purely antagonistic perspective, but
to also consider the beneﬁts of type I IFN signaling for viral processes,
especially for viruses that establish chronic asymptomatic infection in
most infected hosts.marrow derived macrophages isolated from BL6 (Wt) or IFNAR1-/- mice were
nucleofected with indicated reporter constructs or a promoterless vector in
combination with a plasmid encoding constitutively expressed β-gal. Cell lysates
were collected at 16 h post nucleofection, luciferase activity measured, and
normalized to the corresponding β-gal activity. Normalized luciferase data were
pooled from two independent experiments, each experimental condition done in
duplicate within each experiment. Average and standard error of measurement are
shown. B. Primary bone marrow derived BL6 macrophages were mock-treated or
treated with 10U/ml of recombinant IFNβ or IFNγ for 16 h. Following treatment,
macrophages were infected with wt MHV68 at an MOI of 10, and corresponding
treatment (mock, IFNβ, or IFNγ at 10 U/ml) was continued following virus absorp-
tion. Total RNA was harvested at 8 and 24 h post infection and RTA mRNA levels
measured by qRT-PCR. RNA from mock-infected macrophages was used as a
speciﬁcity control. Data is displayed as average with standard error of measure-
ment. *po0.05.Materials and methods
Animals and primary cell cultures
C57BL/6J(BL6) mice were obtained from Jackson Laboratories
(Bar Harbor, ME). IFNAR1-deﬁcient mice (Sun et al., 1998) were
obtained from Dr. Mitchell Grayson. IRF-3 deﬁcient mice were
obtained from Dr. Michael Diamond (Sato et al., 2000). Mice were
bred and housed in a speciﬁc-pathogen-free barrier facility in accor-
dance with institutional and federal guidelines. All experimentalmanipulations of mice were approved by the Institutional Animal
Care and Use Committee of the Medical College of Wisconsin. Bone
marrow was harvested from mice between 3 and 10 weeks of age.
Primary bone marrow derived macrophages were generated as
previously described (Tarakanova et al., 2007).Viral DNA quantitation
Infected cells were washed with PBS and lysed in a buffer
containing 10 mM Tris–Cl, 1 mM EDTA, 0.8% SDS, and 20 μg/ml of
proteinase K (Sigma-Aldrich, St. Louis, MO). Following overnight
protein digestion at 56 1C, DNA was extracted with phenol/chloro-
form and precipitated using standard sodium acetate/ethanol
treatment. DNA pellet was resuspended in TE (10 mM Tris–Cl, pH
8, 1 mM EDTA), viral DNAwas measured by real time PCR using core
B.M. Wood et al. / Virology 443 (2013) 123–133 131gene 50 promoter primers (Mounce et al., 2011b), and normalized
to corresponding GAPDH levels as previously described (Mounce
et al., 2011b).
Quantitative real-time PCR
Total RNA was harvested from cells, DNase treated, and reverse
transcribed as previously described (Mboko et al., 2012). cDNAwas
assessed in triplicate, along with corresponding negative RT
reactions by real time PCR using iCycler (Bio-Rad, Hercules, CA)
(Mboko et al., 2012; Mounce et al., 2011a). Sequences of primers
used for this study were previously published (Mboko et al., 2012;
Tarakanova et al., 2010). Universal IFNα primers were as follows:
forward 5′–ATG GCT AGR CTC GTG CTT TCC T–3′ (R is a wobble of A
or G); reverse 5′–AGG GCT CTC CAG AYT TCT GCT CTG–3′ (Y is a
wobble of C or T). Relative abundance of each cDNA was normal-
ized to corresponding GAPDH levels and quantiﬁed using the ΔCT
method.
Western analysis
Cells were washed with PBS, directly lysed in the Laemmli
buffer, and analyzed as previously described (Mboko et al., 2012;
Mounce et al., 2011a). The antibodies used were anti-β actin
(1:20,000; Novus Biological, Littleton, CO), anti-Y701 phospho-
Stat1 (1:1,000; Millipore, Billerica, MA), anti-total Stat1 (1:3,000;
Santa Cruz Biotechnology, Santa Cruz, CA), anti-ssDBP [1:1000;
(Mounce et al., 2011a)], rabbit anti-mouse ISG15 (1:3000, a gene-
rous gift of Dr. Lenschow), and a secondary goat anti-mouse or
anti-rabbit horseradish peroxidase-conjugated secondary anti-
body (1:25,000; Jackson Immunoresearch, Westgrove, PA).
Interferon treatment
Macrophages were treated with recombinant mouse IFNβ
(Biolegend, San Diego, CA) diluted in tissue culture medium at
concentrations of 10 U/mL or 100 U/mL. Cells were treated either
15 or 60 min prior to lysis. To measure the effect of IFN signaling
on RTA transcription during infection (Fig. 6B), macrophages
derived from bone marrow of BL6 mice were mock-treated or
pretreated with 10 U/ml of recombinant mouse IFNβ or IFNγ for
16 h, infected with wild type MHV68 at an MOI of 10, and
subjected to the same IFN treatment for additional 8 or 24 h.
Viral stock preparation and infections
N36S virus mutant (Hwang et al., 2009; Tarakanova et al., 2007)
and wt MHV68 viral stocks were prepared and titered on NIH 3T12
cells as previously described (Mounce et al., 2011b). Wt MHV68
was inactivated by UV crosslinking (0.75 J/cm2; Stratagene UV
Stratalinker 1800, Agilent Technologies, Santa Clara, CA) prior to
infection. Bone marrow derived macrophages were infected with
either wt, N36S, or UV-inactivated MHV68 at a multiplicity of
infection (MOI) of 10 PFU/cell for 1 h at 37 1C and 5% CO2 to allow
for adsorption, and washed twice with PBS prior to medium
replenishment.
Luciferase reporter constructs
Sequences containing the core and distal RTA promoters were
ampliﬁed using the following primers: core, 5′–TGG-CGG-GTA-
CCG-AAT-CAT-AGA-TTT-TTT-TAG-C–3′ (forward), 5′–GAT-CGC-TAG-
CAG-GTG-GTG-GTT-GCC-AGC-AGG–3′ (reverse); distal, 5′–TGG-
CGG-GTA-CCT-TAA-TCC-TAT-ATG-GAG-AT–3′ (forward), 5′–GAT-
CGC-TAG-CGT-GCT-GGG-TTG-TGA-A–3′ (reverse). Ampliﬁed and
puriﬁed DNA was cloned into the pGL4.10[luc2] vector (Promega,Madison, WI) using KpnI and NheI restriction enzyme sites.
Constructs were veriﬁed by sequencing and puriﬁed on cesium
chloride gradients prior to nucleofection.
Nucleofection of primary bone marrow macrophages
Macrophages were cultured as described previously (Tara-
kanova et al., 2007), cells were lifted on day 10 of culture,
combined with plasmid DNA, and resuspended in Buffer T accord-
ing to manufacturer's instructions (Lonza, Basel, Switzerland).
Electroporation was performed using program T-20 on Amaxa
Nucleofector (Lonza, Basel, Switzerland). At 16 h post transfection,
cells were collected in 1X rapid lysis buffer (Promega, Madison,
WI) and subjected to luciferase assays with subsequent normal-
ization against beta-galactosidase activity.
Luciferase assay
Nucleofected cells were collected in 200 mL 1X rapid lysis buffer
(Promega, Madison, WI) and freeze-thawed twice. 20 mL of lysate
was then subjected to luciferase assay according to the manufac-
turer's recommendations (Promega, Madison, WI) using Victor V3
(PerkinElmer, Waltham, MA).
Beta-galactosidase assay
Nucleofected cell lysate was prepared as described above,
combined with 4 mg/mL ONPG (Sigma Aldrich, St. Louis, MO)
and incubated at 37 1C for 30 m. Absorbance measures were taken
at 420 nm and used to normalize luciferase readings.
IFN bioassay
Conditioned medium (CM) was collected from bone marrow
derived macrophages which were mock-infected or infected with
either live or UV-inactivated wild type MHV68. CM and serially
diluted IFNβ standards were UV irradiated to inactivate live MHV68
(0.25 J/cm2; Fisher Biotech UV Crosslinker FB-UV XL-1000, Fischer
Scientiﬁc, Pittsburgh, PA). Monolayers of L929 cells were overlaid
with CM or diluted IFNβ standards and incubated overnight at 37 1C,
5% CO2. After 24 h, CM was removed, monolayers were infected with
EMCV (B strain) at MOI 5, and incubated for additional 24 h. CellTiter
96 AQeous One Solution Reagent (Promega, Madison, WI) was added
to each well 24 h post infection, according to manufacturer's instruc-
tions, and incubated at 37 1C, 5% CO2 for 45 min. Absorbance (OD)
was measured at 450 nm (1420 Multilabel counter Victor3V, Perki-
nElmer, Waltham, MA). A Non-linear ﬁt regression was performed
(GraphPad Prism, GraphPad, La Jolla, CA) to determine the values
deﬁning the maximum and minimum plateau, and the EC50 for the
standard curve. Concentration of IFN in CM was determined using
the OD450 as follows: Log IU/mL¼ logEC50+Log [(OD450−mini-
mum)/(maximum−OD450)].
Statistical analysis
A Student's T-test (GraphPad Prism, GraphPad, La Jolla, CA) was
used to measure statistical signiﬁcance with an α-value of 0.05.Acknowledgments
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